Hypoxic preconditioning reduces apoptosis in a rat model of immature brain hypoxia-ischaemia

2003 ◽  
Vol 347 (2) ◽  
pp. 106-110 ◽  
Author(s):  
Sylvain Cantagrel ◽  
Catherine Krier ◽  
Sarah Ducrocq ◽  
Sylvie Bodard ◽  
Valérie Payen ◽  
...  
Epilepsia ◽  
2020 ◽  
Author(s):  
Tommi Ala‐Kurikka ◽  
Alexey Pospelov ◽  
Milla Summanen ◽  
Aleksander Alafuzoff ◽  
Samu Kurki ◽  
...  

2012 ◽  
Vol 124 (3) ◽  
pp. 165-176 ◽  
Author(s):  
Ching-Ping Chang ◽  
Chung-Ching Chio ◽  
Chong-Un Cheong ◽  
Chien-Ming Chao ◽  
Bor-Chieh Cheng ◽  
...  

Bone-marrow-derived human MSCs (mesenchymal stem cells) support repair when administered to animals with TBI (traumatic brain injury) in large part through secreted trophic factors. We directly tested the ability of the culture medium (or secretome) collected from human MSCs under normoxic or hypoxic conditions to protect neurons in a rat model of TBI. Concentrated conditioned medium from cultured human MSCs or control medium was infused through the tail vein of rats subjected to TBI. We have demonstrated that MSCs cultured in hypoxia were superior to those cultured in normoxia in inducing expression of both HGF (hepatocyte growth factor) and VEGF (vascular endothelial growth factor) in the cultured medium. We showed further that rats treated with the secretome from both normoxic- and hypoxic-preconditioned MSCs performed significantly better than the controls in both motor and cognitive functional test. Subsequent post-mortem evaluation of brain damage at the 4-day time point confirmed that both normoxic- and hypoxic-preconditioned MSC secretome-treated rats had significantly greater numbers of newly forming neurons, but significantly less than the controls in brain damaged volume and apoptosis. The TBI rats treated with hypoxic-preconditioned MSC secretome performed significantly better in both motor and cognitive function tests and neurogenesis, and had significantly less brain damage than the TBI rats treated with the normoxic-preconditioned MSC secretome. Collectively, these findings suggest that MSCs secrete bioactive factors, including HGF and VEGF, that stimulate neurogenesis and improve outcomes of TBI in a rat model. Hypoxic preconditioning enhances the secretion of these bioactive factors from the MSCs and the therapeutic potential of the cultured MSC secretome in experimental TBI.


2006 ◽  
Vol 27 (5) ◽  
pp. 928-938 ◽  
Author(s):  
Malin Gustavsson ◽  
Carina Mallard ◽  
Susan J Vannucci ◽  
Mary Ann Wilson ◽  
Michael V Johnston ◽  
...  

1999 ◽  
Vol 19 (3) ◽  
pp. 331-340 ◽  
Author(s):  
Jeffrey M. Gidday ◽  
Aarti R. Shah ◽  
Raymond G. Maceren ◽  
Qiong Wang ◽  
Dale A. Pelligrino ◽  
...  

Neuroprotection against cerebral ischemia can be realized if the brain is preconditioned by previous exposure to a brief period of sublethal ischemia. The present study was undertaken to test the hypothesis that nitric oxide (NO) produced from the neuronal isoform of NO synthase (NOS) serves as a necessary signal for establishing an ischemia-tolerant state in brain. A newborn rat model of hypoxic preconditioning was used, wherein exposure to sublethal hypoxia (8% oxygen) for 3 hours renders postnatal day (PND) 6 animals completely resistant to a cerebral hypoxic-ischemic insult imposed 24 hours later. Postnatal day 6 animals were treated 0.5 hour before preconditioning hypoxia with the nonselective NOS inhibitor L-nitroarginine (2 mg/kg intraperitoneally). This treatment, which resulted in a 67 to 81% inhibition of calcium-dependent constitutive NOS activity 0.5 to 3.5 hours after its administration, completely blocked preconditioning-induced protection. However, administration of the neuronal NOS inhibitor 7-nitroindazole (40 mg/kg intraperitoneally) before preconditioning hypoxia, which decreased constitutive brain NOS activity by 58 to 81%, was without effect on preconditioning-induced cerebroprotection, as was pretreatment with the inducible NOS inhibitor aminoguanidine (400 mg/kg intraperitoneally). The protective effects of preconditioning were also not blocked by treating animals with competitive [3-(2-carboxypiperazin-4-yl)propyl-1-phosphonate; 5 mg/kg intraperitoneally] or noncompetitive (MK-801; 1 mg/kg intraperitoneally) N-methyl-D-aspartate receptor antagonists prior to preconditioning hypoxia. These findings indicate that NO production and activity are critical to the induction of ischemic tolerance in this model. However, the results argue against the involvement of the neuronal NOS isoform, activated secondary to a hypoxia-induced stimulation of N-methyl-D-aspartate receptors, and against the involvement of the inducible NOS isoform, but rather suggest that NO produced by the endothelial NOS isoform is required to mediate this profound protective effect.


2020 ◽  
Vol 330 ◽  
pp. 113317 ◽  
Author(s):  
F.K. Odorcyk ◽  
L.E. Duran-Carabali ◽  
D.S. Rocha ◽  
E.F. Sanches ◽  
A.P. Martini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document